These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27403900)

  • 41. PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.
    Huelsmann M; Neuhold S; Resl M; Strunk G; Brath H; Francesconi C; Adlbrecht C; Prager R; Luger A; Pacher R; Clodi M
    J Am Coll Cardiol; 2013 Oct; 62(15):1365-72. PubMed ID: 23810874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Physical training at ambulatory-polyclinical stage in complex rehabilitation and secondary prevention of patients with ischemic heart disease after acute incidents. Effect on physical working capacity, hemodynamics, blood lipids, clinical course and prognosis (Russian cooperative study)].
    Aronov DM; Krasnitskiĭ VB; Bubnova MG; Pozdniakov IuM; Ioseliani DG; Shchegol'kov AN; Efremushkin GG; Osipova IV; Guliaeva SF; Mal'chikova SV; Kazakevich EV; Liamina NP; Riamzina IN; Mingazetdinova LN; Galiautdinov GS; Tin'kov AN; Grinshteĭn IuI; Novikova NK
    Kardiologiia; 2009; 49(3):49-56. PubMed ID: 19257867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Value of plasma NT-proBNP for diagnosing heart failure in patients with previous myocardial infarction].
    Wei BQ; Zhang J; Yang YJ; Lü R; Zhang YH; Zhou Q; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan; 40(1):34-8. PubMed ID: 22490631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy.
    Fröhlich GM; Schoch B; Schmid F; Keller P; Sudano I; Lüscher TF; Noll G; Ruschitzka F; Enseleit F
    Int J Cardiol; 2012 Feb; 154(3):328-32. PubMed ID: 22044675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
    Tang WH; Steinhubl SR; Van Lente F; Brennan D; McErlean E; Maroo A; Francis GS; Topol EJ
    Am Heart J; 2007 Jan; 153(1):36-41. PubMed ID: 17174634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of physical exercise on inflammatory parameters and risk for repeated acute coronary syndrome in patients with ischemic heart disease.
    Ranković G; Milicić B; Savić T; Dindić B; Mancev Z; Pesić G
    Vojnosanit Pregl; 2009 Jan; 66(1):44-8. PubMed ID: 19195263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term benefits of exercise training in patients with a systemic right ventricle.
    van der Bom T; Winter MM; Knaake JL; Cervi E; de Vries LS; Balducci A; Meregalli PG; Pieper PG; van Dijk AP; Bonvicini M; Mulder BJ; Bouma BJ
    Int J Cardiol; 2015 Jan; 179():105-11. PubMed ID: 25464425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
    Ilea M; Zdrenghea D; Bodisz G; Mălai A; Gheorghiu L; Predescu D; Beudean M; Ossian V; Gligor E; Vlad C; Pop D; Bogdan E; Roşu R
    Rom J Intern Med; 2008; 46(1):63-8. PubMed ID: 19157272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes.
    De Servi S; Mariani G; Piatti L; Leoncini M; Rubartelli P; Pitì A; Curello S; Galdangelo F; Vandoni P; Rossetti E; Mariani M; Boschetti E; Re G; Loznicker M
    J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):42-7. PubMed ID: 24492354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of six-week cardiac rehabilitation and exercise on adiponectin in patients with acute coronary syndrome.
    Kim HJ; Oh JK; Kim C; Jee H; Shin KA; Kim YJ
    Kardiol Pol; 2013; 71(9):924-30. PubMed ID: 24065421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial effects of cardiac rehabilitation in patients with incomplete revascularization after primary coronary angioplasty.
    Rechciński T; Kałowski M; Kasprzak JD; Trzos E; Kurpesa M
    Eur J Phys Rehabil Med; 2013 Dec; 49(6):785-91. PubMed ID: 23558697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Special aspects of physical training during the rehabilitation stage of coronary patients].
    Claus J; Eisenriegler E; Grodzinski E; Hollenstein U; Jetté M; Jokiel R; Kottmann W
    Herz; 1991 Aug; 16(4):199-209. PubMed ID: 1916617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.
    Khan SQ; Narayan H; Ng KH; Dhillon OS; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2009 Jun; 117(1):31-9. PubMed ID: 19170658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
    Eggers KM; Venge P; Lind L
    Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Left ventricular dysfunction and NT-proBNP levels in patients with one-vessel disease after first ST-elevation myocardial infarction treated with primary coronary angioplasty.
    Szadkowska I; Pawlicki L; Kowalski J; Banach M; Goch JH; Chizyński K
    Kardiol Pol; 2009 Nov; 67(11):1201-6. PubMed ID: 20024847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.